Juberg-Hayward syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2319OMIM:216100Q87.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Juberg-Hayward syndrome, also known as orocraniodigital syndrome, is an extremely rare congenital malformation syndrome characterized by a combination of craniofacial, limb, and growth abnormalities. The condition was first described by Juberg and Hayward in 1969. Key clinical features include cleft lip and/or cleft palate, microcephaly (abnormally small head), short stature, and thumb abnormalities ranging from hypoplasia (underdevelopment) to aplasia (absence) of the thumbs. Additional hand anomalies may include hypoplastic or absent radii and abnormalities of other fingers. Some affected individuals also demonstrate intellectual disability, although cognitive function can be normal. The syndrome affects multiple body systems, primarily the craniofacial structures, the skeletal system (especially the upper limbs), and growth. Additional features that have been reported in some patients include renal anomalies, vertebral defects, and abnormalities of the toes. The facial features may also include a flat nasal bridge and ptosis (drooping eyelids). There is no specific cure or targeted therapy for Juberg-Hayward syndrome. Management is supportive and symptomatic, typically involving a multidisciplinary team. Surgical repair of cleft lip and palate is often necessary, and orthopedic interventions may be required for limb abnormalities. Speech therapy, developmental support, and regular monitoring of growth and development are important components of care. Genetic counseling is recommended for affected families.

Also known as:

Clinical phenotype terms— hover any for plain English:

HammertoeHP:0001765
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Juberg-Hayward syndrome.

View clinical trials →

No actively recruiting trials found for Juberg-Hayward syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Juberg-Hayward syndrome community →

No specialists are currently listed for Juberg-Hayward syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Juberg-Hayward syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Juberg-Hayward syndromeForum →

No community posts yet. Be the first to share your experience with Juberg-Hayward syndrome.

Start the conversation →

Latest news about Juberg-Hayward syndrome

No recent news articles for Juberg-Hayward syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Juberg-Hayward syndrome

What is Juberg-Hayward syndrome?

Juberg-Hayward syndrome, also known as orocraniodigital syndrome, is an extremely rare congenital malformation syndrome characterized by a combination of craniofacial, limb, and growth abnormalities. The condition was first described by Juberg and Hayward in 1969. Key clinical features include cleft lip and/or cleft palate, microcephaly (abnormally small head), short stature, and thumb abnormalities ranging from hypoplasia (underdevelopment) to aplasia (absence) of the thumbs. Additional hand anomalies may include hypoplastic or absent radii and abnormalities of other fingers. Some affected in

How is Juberg-Hayward syndrome inherited?

Juberg-Hayward syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Juberg-Hayward syndrome typically begin?

Typical onset of Juberg-Hayward syndrome is neonatal. Age of onset can vary across affected individuals.